药物基因组学 (PGx) 诊所对患者满意度和PGx素养的影响
Amanda Massmann1,2, Jordan Baye1,2,3, Max Weaver1
1Sanford Imagenetics, Sanford Health, Sioux Falls, SD, USA.
Pharmacogenomics
|March 21, 2025
概括
药物基因组学 (PGx) 诊所改善了患者对遗传检测结果的理解和满意度. 实施PGx诊所可以提高患者对遗传学如何影响他们的护理计划和药物有效性的信心.
科学领域:
- 药物基因组学 药物基因组学
- 临床药房 临床药房
- 遗传学 遗传学 是一个
背景情况:
- 遗传变异影响个人对药物的反应,这一领域被称为药物基因组学 (PGx).
- 由于复杂的报告,患者对药物基因组测试结果的理解和满意度往往不够理想.
- 了解PGx数据的现有挑战需要改进患者教育和参与策略.
研究的目的:
- 评估药物基因组学 (PGx) 诊所对患者识字,理解和对PGx测试的满意度的影响.
- 为了比较专用PGx诊所和选择性遗传查之间的患者体验.
- 确定PGx服务可以增强的关键领域,以改善患者的治疗结果.
主要方法:
- 调查分发给接受PGx诊所护理的患者和接受选择性基因查 (桑福德芯片) 的患者.
- 这些调查评估了患者的素养,对结果的理解,以及对药物基因组测试过程的整体满意度.
- 用描述性统计数据分析了100个有效的调查答复.
主要成果:
- 与选择性查参与者相比,参加PGx诊所的患者对了解结果,测试对他们的护理计划的贡献以及对药物有效性的信心的满意度明显更高.
- 在PGx诊所的患者表现出明显改善的满意度与结果的沟通和他们的整体经验.
- 识字评估得分显示,所有参与者的理解水平中位数为13分中的9分.
结论:
- 建立一个药物基因组学 (PGx) 诊所显然可以提高患者的体验,信心和满意度.
- 专门的PGx诊所有效地提高了患者对个性化医学遗传信息的理解和参与.
- 将PGx服务集成到临床实践中可以优化基因测试的实用性,以改善患者护理.
相关概念视频
Analysis of Population Pharmacokinetic Data
206
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
206
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Health Literacy
3.9K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
3.9K
Genomics
35.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.6K
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Pharmacokinetics: Overview
5.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.3K


